Photo by cdc from unsplash
Behaviors interfering with medication adherence (MA) are common and often complex in Parkinson's disease (PD), negatively affecting quality of life and undermining the value of clinical trials. The Clinical Outcome… Click to show full abstract
Behaviors interfering with medication adherence (MA) are common and often complex in Parkinson's disease (PD), negatively affecting quality of life and undermining the value of clinical trials. The Clinical Outcome Assessments (COA) Scientific Evaluation Committee of the International Parkinson and Movement Disorder Society (MDS) commissioned the assessment of MA rating scales to recommend the use in PD.
Keywords:
parkinson;
parkinson disease;
medication adherence;
rating scales
Journal Title: Movement Disorders Clinical Practice
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Movement Disorders Clinical Practice
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!